cis-platinum

DRUG8 trials

Conditions

Advanced Non-Small Cell Lung CancerAdvanced Solid TumorsCervical CancerColorectal AdenocarcinomaEsophagus CancerHead and Neck CancerHead and Neck Squamous Cell Carcinoma (HNSCC)Nasopharyngeal Carcinoma

Phase 1

A Study to Evaluate the Safety and Efficacy of SHR-1210, Gemcitabine and Cis-platinum by R/M NPC Subjects

CompletedNCT03121716

Jiangsu HengRui Medicine Co., Ltd.Nasopharyngeal Carcinoma

Start: 2017-04-26End: 2020-07-31Updated: 2022-07-12

Efficacy and Safety of IBI351 in Combination With Chemotherapy in Advanced Non-squamous Non-small Cell Lung Cancer Subjects With KRAS G12C Mutation

RecruitingNCT05504278

Innovent Biologics (Suzhou) Co. Ltd.Advanced Non-Small Cell Lung Cancer

Start: 2022-09-20End: 2027-07-31Target: 144Updated: 2025-01-27

AK129 Combination Therapy for Advanced Solid Tumors

RecruitingNCT06943820

AkesoAdvanced Solid Tumors, Colorectal Adenocarcinoma, Head and Neck Squamous Cell Carcinoma (HNSCC) +1

Start: 2025-05-21End: 2028-05-31Target: 230Updated: 2025-06-03

Phase 2

Erlotinib in Post Radical Operation NSCLC Patients With EGFR Mutation

NCT01683175

Tianjin Medical University Cancer Institute and HospitalNon-small Cell Lung Cancer Stage III

Start: 2012-08-31End: 2020-10-31Updated: 2016-10-20

Tislelizumab Combined With Chemotherapy for Resectable Esophageal Squamous Cell Carcinoma Followed by CRT or Surgery

Not yet recruitingNCT07046221

Fujian Cancer HospitalEsophagus Cancer

Start: 2025-08-01End: 2030-08-01Target: 60Updated: 2025-07-20

Phase 3

Comparison of Postoperative Adjuvant Chemotherapy With/Without Rh-endostatin on Non-small Cell Lung Cancer in PhaseⅠB

NCT02001168

Xinjiang Medical UniversityNon-small Cell Lung Cancer

Start: 2013-10-31End: 2022-10-31Target: 392Updated: 2013-12-04

Phase 4

A Trial of Nimotuzumab and Pinkiller Efficacy and Pain in Advanced Head and Neck Squamous Cell Carcinoma

Active, not recruitingNCT06879691

Biotech Pharmaceutical Co., Ltd.Head and Neck Cancer

Start: 2021-05-15End: 2025-04-14Target: 171Updated: 2025-03-17

Unknown Phase

Envafolimab Combined With Endostar and Concurrent Chemoradiotherapy for Locally Advanced Primary Cervical Cancer

Not yet recruitingNCT05879796

Peking University Third HospitalCervical Cancer

Start: 2023-05-16End: 2026-05-16Target: 30Updated: 2023-05-30

BMC Medicine2025-02-274 citations

Updated overall survival (OS) and exploratory analysis from the randomized, phase II EVAN study of erlotinib (E) versus vinorelbine plus cisplatin (NP) as adjuvant therapy in Chinese patients with stage IIIA EGFR+ NSCLC.

Journal of Clinical Oncology2021-05-2010 citations

Camrelizumab (SHR-1210) alone or in combination with gemcitabine plus cisplatin for nasopharyngeal carcinoma: results from two single-arm, phase 1 trials.

2018-09-10373 citations

Erlotinib versus vinorelbine plus cisplatin as adjuvant therapy in Chinese patients with stage IIIA EGFR mutation-positive non-small-cell lung cancer (EVAN): a randomised, open-label, phase 2 trial.

2018-08-24233 citations